Literature DB >> 18365372

HLA-DR antibody epitopes.

Junchao Cai1, Sam Kohanof, Paul I Terasaki.   

Abstract

A single antigen (SA) Luminex beads assay was used to detect antibody specificities of allosera and monoclonal antibodies. Potential antibody epitopes were mapped by comparing the protein sequence differences of a group of HLA alleles that are either recognized or unrecognized by tested samples. A total of 61 epitopes, including 43 one amino acid (AA) epitopes, 11 two AA epitopes, and 7 epitopes with more than two residues involved, were identified. Among 38 residues constituting DR epitopes, 26 of them located in beta1 domain and 12 located in beta2 domain. Only 42% of beta1 domain epitopes are surface residues, while 83% of beta2 domain epitopes are on an antigen surface. These findings imply that some polymorphic AA residues, especially those on beta1 domain, may be indirectly involved in antibody-antigen interactions. In conclusion, sequence comparison following SA beads tests provides an ideal approach for epitope identification of HLA-specific antibody. Certainly, these identified potential epitopes need to be further proved or disproved by other approaches, such as absorption/elution from SA beads or cell lines, each of which contains unique epitope pattern.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18365372

Source DB:  PubMed          Journal:  Clin Transpl        ISSN: 0890-9016


  2 in total

1.  Why can sensitization by an HLA-DR2 mismatch lead to antibodies that react also with HLA-DR1?

Authors:  Marilyn Marrari; Rene J Duquesnoy
Journal:  Hum Immunol       Date:  2009-03-09       Impact factor: 2.850

2.  Generation and reactivity analysis of human recombinant monoclonal antibodies directed against epitopes on HLA-DR.

Authors:  Cynthia S M Kramer; Marry E I Franke-van Dijk; Kim H Bakker; Merve Uyar-Mercankaya; Gonca E Karahan; Dave L Roelen; Frans H J Claas; Sebastiaan Heidt
Journal:  Am J Transplant       Date:  2020-05-15       Impact factor: 8.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.